✦ LIBER ✦

962 Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Levels in Patients with Inflammatory Bowel Disease

✍ Scribed by Waqqas Afif; Edward V. Loftus; William A. Faubion; Karen A. Hanson; William J. Sandborn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Value of Measuring Trough Level

✍ Pariente, Benjamin ;Pineton de Chambrun, Guillaume ;Desroches, Marine ;De Cassan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Clinical implications of variations in a

✍ Casper Steenholdt; Magid Al-khalaf; Jørn Brynskov; Klaus Bendtzen; Ole Ø. Thomse 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

Impact of measurement of infliximab and

✍ Cardile, S.; Costa, A.; Loddo, I.; Morabito, G.; Pidone, C.; Romano, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

P544 Does measuring IFX and human anti-c

✍ Chauhan, U.; Dutta, U.; Armstrong, D.; Marshall, J.; Tse, F.; Greenwald, E.; Xen 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 55 KB

Impact of Antibodies to Infliximab on Cl

✍ Nanda, Kavinderjit S; Cheifetz, Adam S; Moss, Alan C 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Sa1289 Analysis of Clinical and Serologi

✍ Sundip S. Karsan; Erica R. Cohen; Stephan R. Targan; Andrew Ippoliti; David Q. S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 95 KB